Posted by Michael Wonder on 04 Jul 2021
Sonic Healthcare USA to offer assay to aid in the selection of Jemperli (dostarlimab-gxly) therapy in endometrial cancer
2 July 2021 - LMC Pathology Services, a Sonic Healthcare USA Anatomic Pathology Practice, is the first reference laboratory in the United States to offer the Ventana MMR RxDx Panel from Roche Diagnostics for evaluation of endometrial cancer, approved by the FDA on 22 April 2021.
Aurora Research Institute, also a part of Sonic Healthcare USA’s Anatomic Pathology Division, served as a research test site to collect data to support Roche’s submission for U.S. FDA approval of the test.
